Downstream Processability of Crystal Habit-Modified Active Pharmaceutical Ingredient
暂无分享,去创建一个
Jukka Rantanen | Andrew D. Bond | J. Rantanen | N. Pudasaini | C. R. Parker | Stefan U. Hagen | A. Bond | Nawin Pudasaini | Pratik P. Upadhyay | Christian R. Parker | P. Upadhyay
[1] Hydrogen bonds in the crystal packings of mesalazine and mesalazine hydrochloride , 1997 .
[2] Changquan Calvin Sun,et al. Quantifying effects of particulate properties on powder flow properties using a ring shear tester. , 2008, Journal of pharmaceutical sciences.
[3] Changquan Calvin Sun,et al. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression. , 2016, Journal of pharmaceutical and biomedical analysis.
[4] A. Bansal,et al. Modification of the crystal habit of celecoxib for improved processability , 2007, The Journal of pharmacy and pharmacology.
[5] T. Lundstedt,et al. Application of Multivariate Analysis in Pharmaceutical Development Work , 1995 .
[6] I. Sˇirola,et al. Effect of crystal size and shape on bulk density of pharmaceutical powders , 1997 .
[7] Andrea R. Browning,et al. Crystal Shape Engineering , 2008 .
[8] A. Rohl. Computer prediction of crystal morphology , 2003 .
[9] Changquan Calvin Sun,et al. Development of a high drug load tablet formulation based on assessment of powder manufacturability: moving towards quality by design. , 2009, Journal of pharmaceutical sciences.
[10] J. Newton,et al. Determination of tablet strength by the diametral-compression test. , 1970, Journal of pharmaceutical sciences.
[11] Changquan Calvin Sun. Quantifying effects of moisture content on flow properties of microcrystalline cellulose using a ring shear tester , 2016 .
[12] Sampsa Laine,et al. Visualization of particle size and shape distributions using self-organizing maps , 2002 .
[13] Matthew G. Heasley,et al. Determination of the tensile strength of elongated tablets , 2013 .
[14] Michał Teżyk,et al. Recent progress in continuous and semi-continuous processing of solid oral dosage forms: a review , 2016, Drug development and industrial pharmacy.
[15] Robin Taylor,et al. New software for searching the Cambridge Structural Database and visualizing crystal structures. , 2002, Acta crystallographica. Section B, Structural science.
[16] Michael Leane,et al. A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms , 2015, Pharmaceutical development and technology.
[17] Jukka Rantanen,et al. Evaluation of ring shear testing as a characterization method for powder flow in small-scale powder processing equipment. , 2014, International journal of pharmaceutics.
[18] J. Yliruusi,et al. Development of a New Method to Get a Reliable Powder Flow Characteristics Using Only 1 to 2 g of Powder , 2010, AAPS PharmSciTech.
[19] I. Bruno,et al. Cambridge Structural Database , 2002 .
[20] Changquan Calvin Sun,et al. Influence of Crystal Structure on the Tableting Properties of Sulfamerazine Polymorphs , 2001, Pharmaceutical Research.
[21] A. Bansal,et al. Spherical Crystallization of Mebendazole to Improve Processability , 2008 .
[22] Changquan Calvin Sun,et al. Impact of Crystal Habit on Biopharmaceutical Performance of Celecoxib , 2013 .
[23] L. Christrup,et al. Patients' evaluation of shape, size and colour of solid dosage forms , 2001, Pharmacy World and Science.
[24] M. Ward,et al. Face-Discriminating Dissolution Kinetics of Furosemide Single Crystals: In Situ Three-Dimensional Multi-Microscopy and Modeling , 2016 .